Jing Chen, PhD

Titles and Roles

Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Co-Director, Experimental Therapeutics Program in Leukemia
Winship Cancer Institute of Emory University
Research Program
Cancer Cell Biology


Jing Chen, PhD, is a Professor of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Chen is a member of the Cancer Cell Biology research program at Winship Cancer Institute.


Dr. Chen obtained his PhD in Biochemistry and Cell Biology at Emory University, and was trained as an HHMI Postdoctoral Fellow in Dr. Gary Gilliland's laboratory at Harvard Medical School before joining Winship Cancer Institute as an Assistant Professor in 2004.


Dr. Chen is interested in the role of post-translational modifications including phosphorylation, acetylation and ubiquitination in human cancers, with a particular focus on oncogenesis, metastasis and cancer metabolism.

Dr. Chen's team is interested in exploration of the signaling network of leukemogenic tyrosine kinases that regulate leukemogenesis and disease progression, and in translating the insights obtained in basic research to clinical applications. His group focuses on the signaling properties of the target cancer-initiating stem cells that may provide the "right" signaling network for oncogenes to give rise to either myeloid or lymphoid leukemia. These studies will provide alternative targets for curative therapy of leukemia.


Dr. Chen has extensive publications in major peer-reviewed journals such as Science Signaling, Cancer Cell, Journal of Clinical Investigation, PNAS and Blood


Dr. Chen has earned numerous prestigious awards including American Cancer Society Basic Research Scholar Award, The Leukemia & Lymphoma Society Scholar Award and Georgia Cancer Coalition Distinguished Cancer Scholar Award. His research is funded by NIH, American Cancer Society, The Leukemia & Lymphoma Society and other notable foundations.

Dr. Chen also serves as a Reviewer in the Cancer Drug Discovery panel of Grant Review Committee, American Cancer Society.

Additional Websites

Cascade Link   TOP